Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs

BACKGROUND: Surgical resection is the standard of care for the treatment of pancreatic neuro-endocrine tumors (pNETs) in patients with Multiple Endocrine Neoplasia Type 1 (MEN1). However, surgery can cause significant short- and long-term morbidity. Magnetic resonance-guided radiotherapy (MRgRT) is...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vliembergen, Eline N. M., Eijkelenkamp, Hidde, Valk, Gerlof D., Vriens, Menno R., Meijer, Gert J., Intven, Martijn P. W., de Laat, Joanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250693/
https://www.ncbi.nlm.nih.gov/pubmed/37305036
http://dx.doi.org/10.3389/fendo.2023.994370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250693/
https://www.ncbi.nlm.nih.gov/pubmed/37305036
http://dx.doi.org/10.3389/fendo.2023.994370

Ejemplares similares